Free Trial

Lifeway Foods (LWAY) Financials

Lifeway Foods logo
$22.40 +0.10 (+0.45%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$22.42 +0.02 (+0.07%)
As of 05/23/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Lifeway Foods

Annual Income Statements for Lifeway Foods

This table shows Lifeway Foods' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
9.03 11 0.92
Consolidated Net Income / (Loss)
9.03 11 0.92
Net Income / (Loss) Continuing Operations
9.03 11 0.92
Total Pre-Tax Income
14 17 1.84
Total Operating Income
14 17 2.35
Total Gross Profit
49 42 27
Total Revenue
187 160 142
Operating Revenue
187 160 142
Total Cost of Revenue
138 118 115
Operating Cost of Revenue
138 118 115
Total Operating Expenses
35 25 24
Selling, General & Admin Expense
34 25 24
Amortization Expense
0.54 0.54 0.54
Total Other Income / (Expense), net
0.12 -0.35 -0.51
Interest Expense
0.11 0.38 0.27
Other Income / (Expense), net
0.22 0.04 -0.24
Income Tax Expense
4.94 5.28 0.92
Basic Earnings per Share
$0.61 $0.77 $0.06
Weighted Average Basic Shares Outstanding
14.77M 14.67M 15.40M
Diluted Earnings per Share
$0.60 $0.75 $0.06
Weighted Average Diluted Shares Outstanding
15.13M 15.10M 15.72M
Weighted Average Basic & Diluted Shares Outstanding
15.20M 14.69M 14.64M

Quarterly Income Statements for Lifeway Foods

This table shows Lifeway Foods' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-0.16 2.98 3.78 2.43 3.97 3.41 3.16 0.83 0.72 0.98
Consolidated Net Income / (Loss)
-0.16 2.98 3.78 2.43 3.97 3.41 3.16 0.83 0.72 0.98
Net Income / (Loss) Continuing Operations
-0.16 2.98 3.78 2.43 3.97 3.41 3.16 0.83 0.72 0.98
Total Pre-Tax Income
0.78 4.33 5.36 3.51 5.70 4.93 4.69 1.34 1.64 1.11
Total Operating Income
0.71 4.19 5.39 3.56 5.75 5.04 4.77 1.44 1.96 1.20
Total Gross Profit
12 12 13 12 12 11 11 8.23 7.92 7.59
Total Revenue
47 46 49 45 42 41 39 38 36 38
Operating Revenue
47 46 49 45 42 41 39 38 36 38
Total Cost of Revenue
35 34 36 33 30 30 28 30 28 31
Operating Cost of Revenue
35 34 36 33 30 30 28 30 28 31
Total Operating Expenses
11 7.68 7.89 7.97 6.04 6.10 6.51 6.79 5.96 6.39
Selling, General & Admin Expense
11 7.54 7.75 7.84 5.90 5.97 6.38 6.65 5.82 6.26
Amortization Expense
0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14
Total Other Income / (Expense), net
0.06 0.14 -0.03 -0.06 -0.06 -0.11 -0.08 -0.10 -0.33 -0.08
Interest Expense
0.00 0.00 0.05 0.05 0.06 0.11 0.11 0.10 0.10 0.08
Other Income / (Expense), net
0.07 0.14 0.02 -0.01 0.01 -0.00 0.03 0.01 -0.23 -0.01
Income Tax Expense
0.94 1.35 1.58 1.08 1.73 1.52 1.53 0.51 0.92 0.13
Basic Earnings per Share
($0.02) $0.20 $0.26 $0.17 $0.26 $0.23 $0.22 $0.06 $0.05 $0.06
Weighted Average Basic Shares Outstanding
14.77M 14.80M 14.73M 14.69M 14.67M 14.68M 14.65M 14.65M 15.40M 15.49M
Weighted Average Diluted Shares Outstanding
15.13M 15.27M 15.20M 15.22M 15.10M 15.10M 15.08M 15.03M 15.72M 15.85M
Weighted Average Basic & Diluted Shares Outstanding
15.20M 14.82M 14.79M 14.71M 14.69M 14.69M 14.67M 14.66M 14.64M 15.50M

Annual Cash Flow Statements for Lifeway Foods

This table details how cash moves in and out of Lifeway Foods' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents
3.53 8.75 -4.79
Net Cash From Operating Activities
13 17 3.99
Net Cash From Continuing Operating Activities
13 17 3.99
Net Income / (Loss) Continuing Operations
9.03 11 0.92
Consolidated Net Income / (Loss)
9.03 11 0.92
Depreciation Expense
3.39 3.16 2.97
Non-Cash Adjustments To Reconcile Net Income
2.47 1.47 1.36
Changes in Operating Assets and Liabilities, net
-1.92 0.94 -1.27
Net Cash From Investing Activities
-6.68 -4.41 -4.03
Net Cash From Continuing Investing Activities
-6.68 -4.41 -4.03
Purchase of Property, Plant & Equipment
-6.70 -4.35 -3.45
Purchase of Investments
0.00 -0.10 0.00
Sale of Property, Plant & Equipment
0.02 0.04 0.00
Net Cash From Financing Activities
-2.75 -3.78 -4.75
Net Cash From Continuing Financing Activities
-2.75 -3.78 -4.75
Repayment of Debt
-2.75 -3.78 -0.75
Cash Interest Paid
0.10 0.42 0.25
Cash Income Taxes Paid
5.99 4.79 1.12

Quarterly Cash Flow Statements for Lifeway Foods

This table details how cash moves in and out of Lifeway Foods' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-3.83 5.93 2.61 -1.17 0.57 5.18 2.24 0.77 -4.49 2.44
Net Cash From Operating Activities
-2.58 7.45 6.54 1.55 4.80 6.69 2.43 3.03 0.35 4.17
Net Cash From Continuing Operating Activities
-2.58 7.45 6.54 1.55 4.80 6.69 2.43 3.03 0.35 4.17
Net Income / (Loss) Continuing Operations
-0.16 2.98 3.78 2.43 3.97 3.41 3.16 0.83 0.72 0.98
Consolidated Net Income / (Loss)
-0.16 2.98 3.78 2.43 3.97 3.41 3.16 0.83 0.72 0.98
Depreciation Expense
0.90 0.86 0.84 0.80 0.80 0.79 0.79 0.78 0.73 0.73
Non-Cash Adjustments To Reconcile Net Income
0.56 0.60 0.64 0.68 0.42 0.43 0.28 0.35 0.60 0.21
Changes in Operating Assets and Liabilities, net
-3.88 3.02 1.28 -2.35 -0.40 2.06 -1.80 1.07 -1.70 2.25
Net Cash From Investing Activities
-1.25 -1.53 -1.44 -2.47 -1.20 -1.26 -0.19 -1.76 -0.84 -1.48
Net Cash From Continuing Investing Activities
-1.25 -1.53 -1.44 -2.47 -1.20 -1.26 -0.19 -1.76 -0.84 -1.48
Purchase of Property, Plant & Equipment
-1.25 -1.54 -1.44 -2.47 -1.21 -1.16 -0.23 -1.76 -0.84 -0.90
Sale of Property, Plant & Equipment
0.00 0.01 - - 0.00 - - - - -
Cash Interest Paid
0.00 0.01 0.04 0.05 0.07 0.11 0.11 0.13 0.09 0.07
Cash Income Taxes Paid
1.13 1.55 1.38 1.93 1.52 2.30 0.93 0.05 0.48 -

Annual Balance Sheets for Lifeway Foods

This table presents Lifeway Foods' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
91 82 69
Total Current Assets
44 38 27
Cash & Equivalents
17 13 4.44
Accounts Receivable
15 14 11
Inventories, net
8.68 9.10 9.63
Prepaid Expenses
2.14 2.02 1.45
Current Deferred & Refundable Income Taxes
0.63 0.00 0.04
Plant, Property, & Equipment, net
27 23 21
Total Noncurrent Assets
20 21 21
Goodwill
12 12 12
Intangible Assets
6.36 6.90 7.44
Other Noncurrent Operating Assets
2.02 2.09 1.97
Total Liabilities & Shareholders' Equity
91 82 69
Total Liabilities
19 21 21
Total Current Liabilities
16 17 13
Short-Term Debt
0.00 1.25 1.25
Accounts Payable
10 9.98 7.98
Accrued Expenses
5.10 4.92 3.81
Current Deferred & Payable Income Tax Liabilities
0.00 0.47 0.00
Total Noncurrent Liabilities
3.13 4.60 8.39
Long-Term Debt
0.00 1.48 5.25
Noncurrent Deferred & Payable Income Tax Liabilities
3.06 3.00 3.03
Other Noncurrent Operating Liabilities
0.07 0.12 0.10
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
72 60 48
Total Preferred & Common Equity
72 60 48
Preferred Stock
0.00 0.00 0.00
Total Common Equity
72 60 48
Common Stock
11 11 10
Retained Earnings
75 66 54
Treasury Stock
-14 -17 -17

Quarterly Balance Sheets for Lifeway Foods

This table presents Lifeway Foods' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
91 85 83 80 72 71 74
Total Current Assets
45 39 38 37 30 28 32
Cash & Equivalents
21 15 12 13 7.45 5.21 8.93
Accounts Receivable
13 15 15 13 11 12 12
Inventories, net
8.44 8.45 8.13 9.32 9.67 9.29 9.19
Prepaid Expenses
1.89 1.49 1.99 1.62 1.21 1.07 1.37
Current Deferred & Refundable Income Taxes
0.38 0.18 0.38 0.26 0.00 0.00 0.65
Plant, Property, & Equipment, net
26 25 25 22 22 22 21
Total Noncurrent Assets
20 20 21 21 21 21 21
Goodwill
12 12 12 12 12 12 12
Intangible Assets
6.49 6.63 6.76 7.03 7.17 7.30 7.57
Other Noncurrent Operating Assets
2.04 2.05 2.07 2.10 1.94 1.95 1.94
Total Liabilities & Shareholders' Equity
91 85 83 80 72 71 74
Total Liabilities
20 17 19 24 20 22 23
Total Current Liabilities
17 14 15 16 12 14 14
Short-Term Debt
0.00 0.00 1.25 1.25 1.25 1.00 1.00
Accounts Payable
11 9.37 10 9.10 5.57 9.15 9.12
Accrued Expenses
5.59 4.49 3.60 5.56 4.29 3.23 4.38
Current Deferred & Payable Income Tax Liabilities
0.00 0.00 0.00 0.50 1.02 0.42 0.00
Total Noncurrent Liabilities
3.08 3.09 4.34 7.67 7.86 8.12 8.78
Long-Term Debt
0.00 0.00 1.24 4.51 4.76 5.01 5.50
Noncurrent Deferred & Payable Income Tax Liabilities
3.00 3.00 3.00 3.03 3.03 3.03 3.20
Other Noncurrent Operating Liabilities
0.08 0.09 0.10 0.13 0.07 0.09 0.07
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
72 68 64 56 52 49 50
Total Preferred & Common Equity
72 68 64 56 52 49 50
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
72 68 64 56 52 49 50
Common Stock
12 12 12 11 11 10 9.78
Retained Earnings
75 72 68 62 58 55 54
Treasury Stock
-16 -16 -17 -17 -17 -17 -13

Annual Metrics And Ratios for Lifeway Foods

This table displays calculated financial ratios and metrics derived from Lifeway Foods' official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
16.67% 13.11% 18.90%
EBITDA Growth
-13.54% 297.54% -40.96%
EBIT Growth
-17.37% 708.02% -63.22%
NOPAT Growth
-22.87% 884.19% -65.99%
Net Income Growth
-20.60% 1,130.19% -72.09%
EPS Growth
-20.00% 1,150.00% -71.43%
Operating Cash Flow Growth
-23.49% 324.91% -28.34%
Free Cash Flow Firm Growth
-66.81% 962.32% 34.12%
Invested Capital Growth
10.43% 0.69% 5.27%
Revenue Q/Q Growth
2.66% 4.07% 3.56%
EBITDA Q/Q Growth
-21.86% 25.46% 35.07%
EBIT Q/Q Growth
-26.14% 30.97% 169.57%
NOPAT Q/Q Growth
-31.97% 36.32% 633.02%
Net Income Q/Q Growth
-31.39% 40.09% 703.48%
EPS Q/Q Growth
-29.41% 36.36% 500.00%
Operating Cash Flow Q/Q Growth
-36.27% 35.61% 19.09%
Free Cash Flow Firm Q/Q Growth
-66.92% 50.73% 4.05%
Invested Capital Q/Q Growth
8.28% 1.76% 3.25%
Profitability Metrics
- - -
Gross Margin
26.00% 26.51% 18.92%
EBITDA Margin
9.35% 12.61% 3.59%
Operating Margin
7.41% 10.61% 1.66%
EBIT Margin
7.53% 10.64% 1.49%
Profit (Net Income) Margin
4.83% 7.10% 0.65%
Tax Burden Percent
64.61% 68.27% 50.19%
Interest Burden Percent
99.25% 97.75% 87.33%
Effective Tax Rate
35.39% 31.73% 49.81%
Return on Invested Capital (ROIC)
17.02% 23.30% 2.44%
ROIC Less NNEP Spread (ROIC-NNEP)
16.47% 28.92% -686.66%
Return on Net Nonoperating Assets (RNNOA)
-3.38% -2.25% -0.53%
Return on Equity (ROE)
13.64% 21.05% 1.91%
Cash Return on Invested Capital (CROIC)
7.11% 22.61% -2.70%
Operating Return on Assets (OROA)
16.35% 22.61% 3.01%
Return on Assets (ROA)
10.48% 15.09% 1.32%
Return on Common Equity (ROCE)
13.64% 21.05% 1.91%
Return on Equity Simple (ROE_SIMPLE)
12.55% 18.81% 1.94%
Net Operating Profit after Tax (NOPAT)
8.95 12 1.18
NOPAT Margin
4.79% 7.25% 0.83%
Net Nonoperating Expense Percent (NNEP)
0.56% -5.62% 689.10%
Return On Investment Capital (ROIC_SIMPLE)
12.45% 18.37% -
Cost of Revenue to Revenue
74.00% 73.49% 81.08%
SG&A Expenses to Revenue
18.30% 15.55% 16.88%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
18.59% 15.89% 17.26%
Earnings before Interest and Taxes (EBIT)
14 17 2.11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
17 20 5.08
Valuation Ratios
- - -
Price to Book Value (P/BV)
5.11 3.26 1.81
Price to Tangible Book Value (P/TBV)
6.82 4.71 3.03
Price to Revenue (P/Rev)
1.97 1.23 0.61
Price to Earnings (P/E)
40.71 17.33 93.07
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
2.46% 5.77% 1.07%
Enterprise Value to Invested Capital (EV/IC)
6.36 3.73 1.77
Enterprise Value to Revenue (EV/Rev)
1.88 1.17 0.62
Enterprise Value to EBITDA (EV/EBITDA)
20.09 9.24 17.33
Enterprise Value to EBIT (EV/EBIT)
24.92 10.95 41.77
Enterprise Value to NOPAT (EV/NOPAT)
39.19 16.08 74.69
Enterprise Value to Operating Cash Flow (EV/OCF)
27.06 11.01 22.09
Enterprise Value to Free Cash Flow (EV/FCFF)
93.84 16.56 0.00
Leverage & Solvency
- - -
Debt to Equity
0.00 0.05 0.14
Long-Term Debt to Equity
0.00 0.02 0.11
Financial Leverage
-0.21 -0.08 0.00
Leverage Ratio
1.30 1.39 1.45
Compound Leverage Factor
1.29 1.36 1.26
Debt to Total Capital
0.00% 4.33% 12.03%
Short-Term Debt to Total Capital
0.00% 1.98% 2.31%
Long-Term Debt to Total Capital
0.00% 2.35% 9.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 95.67% 87.97%
Debt to EBITDA
0.00 0.14 1.28
Net Debt to EBITDA
0.00 -0.52 0.41
Long-Term Debt to EBITDA
0.00 0.07 1.03
Debt to NOPAT
0.00 0.24 5.52
Net Debt to NOPAT
0.00 -0.90 1.75
Long-Term Debt to NOPAT
0.00 0.13 4.46
Altman Z-Score
15.94 9.67 5.91
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
2.81 2.30 2.07
Quick Ratio
2.07 1.63 1.22
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
3.74 11 -1.31
Operating Cash Flow to CapEx
193.98% 393.06% 115.60%
Free Cash Flow to Firm to Interest Expense
35.59 29.33 -4.89
Operating Cash Flow to Interest Expense
123.45 44.12 14.93
Operating Cash Flow Less CapEx to Interest Expense
59.81 32.89 2.02
Efficiency Ratios
- - -
Asset Turnover
2.17 2.13 2.02
Accounts Receivable Turnover
12.75 12.66 13.27
Inventory Turnover
15.55 12.56 12.81
Fixed Asset Turnover
7.53 7.33 6.90
Accounts Payable Turnover
13.57 13.11 15.73
Days Sales Outstanding (DSO)
28.62 28.82 27.52
Days Inventory Outstanding (DIO)
23.47 29.05 28.49
Days Payable Outstanding (DPO)
26.90 27.84 23.20
Cash Conversion Cycle (CCC)
25.20 30.03 32.80
Capital & Investment Metrics
- - -
Invested Capital
55 50 50
Invested Capital Turnover
3.55 3.22 2.93
Increase / (Decrease) in Invested Capital
5.21 0.34 2.49
Enterprise Value (EV)
351 187 88
Market Capitalization
367 197 86
Book Value per Share
$4.85 $4.11 $3.07
Tangible Book Value per Share
$3.63 $2.85 $1.83
Total Capital
72 63 54
Total Debt
0.00 2.73 6.50
Total Long-Term Debt
0.00 1.48 5.25
Net Debt
-17 -10 2.06
Capital Expenditures (CapEx)
6.68 4.31 3.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)
11 9.63 11
Debt-free Net Working Capital (DFNWC)
28 23 15
Net Working Capital (NWC)
28 22 14
Net Nonoperating Expense (NNE)
-0.08 0.24 0.25
Net Nonoperating Obligations (NNO)
-17 -10 2.06
Total Depreciation and Amortization (D&A)
3.39 3.16 2.97
Debt-free, Cash-free Net Working Capital to Revenue
6.09% 6.02% 7.59%
Debt-free Net Working Capital to Revenue
15.04% 14.26% 10.73%
Net Working Capital to Revenue
15.04% 13.48% 9.84%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.61 $0.77 $0.06
Adjusted Weighted Average Basic Shares Outstanding
14.77M 14.67M 15.40M
Adjusted Diluted Earnings per Share
$0.60 $0.75 $0.06
Adjusted Weighted Average Diluted Shares Outstanding
15.13M 15.10M 15.72M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.20M 14.69M 14.64M
Normalized Net Operating Profit after Tax (NOPAT)
8.95 12 1.18
Normalized NOPAT Margin
4.79% 7.25% 0.83%
Pre Tax Income Margin
7.48% 10.40% 1.30%
Debt Service Ratios
- - -
EBIT to Interest Expense
134.04 44.36 7.90
NOPAT to Interest Expense
85.23 30.22 4.42
EBIT Less CapEx to Interest Expense
70.40 33.13 -5.02
NOPAT Less CapEx to Interest Expense
21.59 18.99 -8.50
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 432.58%

Quarterly Metrics And Ratios for Lifeway Foods

This table displays calculated financial ratios and metrics derived from Lifeway Foods' official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
11.50% 12.71% 25.30% 17.76% 17.45% 7.23% 17.14% 11.16% 15.70% 29.06%
EBITDA Growth
-74.43% -11.02% 11.86% 95.73% 166.25% 204.28% 481.86% 959.07% 115.10% 11.66%
EBIT Growth
-86.47% -14.05% 12.77% 146.81% 232.70% 323.36% 1,922.78% 237.33% 327.41% 14.75%
NOPAT Growth
-103.67% -17.38% 18.42% 176.50% 366.48% 230.50% 1,953.78% 221.40% 921.47% 112.09%
Net Income Growth
-104.03% -12.78% 19.87% 192.29% 454.33% 247.10% 2,530.00% 192.74% 869.89% 104.79%
EPS Growth
0.00% -17.39% 19.05% 166.67% 400.00% 283.33% 2,000.00% 200.00% 0.00% 100.00%
Operating Cash Flow Growth
-153.76% 11.39% 169.52% -48.93% 1,278.45% 60.48% 1,940.34% 567.13% 219.59% 88.77%
Free Cash Flow Firm Growth
-246.14% -58.22% -36.12% -54.29% 325.55% 624.70% 126.81% 77.40% 70.73% 89.38%
Invested Capital Growth
10.43% 3.79% 5.19% 8.99% 0.69% 2.16% 2.80% 4.61% 5.27% 3.27%
Revenue Q/Q Growth
1.82% -6.23% 10.13% 6.04% 2.93% 4.25% 3.50% 5.76% -6.04% 13.88%
EBITDA Q/Q Growth
-67.64% -16.93% 43.33% -33.64% 12.63% 4.43% 150.79% -9.74% 28.72% 99.69%
EBIT Q/Q Growth
-82.01% -19.90% 51.90% -38.20% 14.31% 5.09% 232.45% -16.70% 45.46% 402.11%
NOPAT Q/Q Growth
-105.10% -24.21% 54.26% -38.51% 14.90% 8.65% 260.17% 3.75% -18.59% 575.15%
Net Income Q/Q Growth
-105.38% -21.33% 55.94% -38.88% 16.32% 8.11% 280.24% 15.92% -27.16% 719.17%
EPS Q/Q Growth
0.00% -24.00% 56.25% -36.00% 8.70% 9.52% 250.00% 20.00% -16.67% 500.00%
Operating Cash Flow Q/Q Growth
-134.61% 13.86% 323.29% -67.77% -28.29% 175.49% -19.79% 769.83% -91.65% 3,402.52%
Free Cash Flow Firm Q/Q Growth
-623.98% -12.44% 158.66% -154.30% 49.79% 33.88% 241.68% 20.62% -248.45% 93.16%
Invested Capital Q/Q Growth
8.28% -4.50% -1.17% 8.05% 1.76% -3.20% 2.40% -0.18% 3.25% -2.60%
Profitability Metrics
- - - - - - - - - -
Gross Margin
25.35% 25.74% 27.01% 25.84% 28.01% 27.25% 28.75% 21.70% 22.10% 19.90%
EBITDA Margin
3.58% 11.25% 12.70% 9.76% 15.59% 14.25% 14.22% 5.87% 6.88% 5.02%
Operating Margin
1.52% 9.09% 10.96% 7.98% 13.67% 12.32% 12.15% 3.79% 5.47% 3.13%
EBIT Margin
1.66% 9.39% 11.00% 7.97% 13.68% 12.32% 12.22% 3.80% 4.83% 3.12%
Profit (Net Income) Margin
-0.34% 6.46% 7.70% 5.44% 9.43% 8.34% 8.04% 2.19% 2.00% 2.58%
Tax Burden Percent
-20.62% 68.79% 70.59% 69.16% 69.67% 69.22% 67.36% 62.03% 43.79% 88.32%
Interest Burden Percent
99.61% 99.91% 99.13% 98.57% 98.92% 97.84% 97.73% 92.79% 94.45% 93.53%
Effective Tax Rate
120.62% 31.21% 29.41% 30.84% 30.33% 30.78% 32.64% 37.97% 56.21% 11.68%
Return on Invested Capital (ROIC)
-1.11% 22.74% 26.27% 17.80% 30.62% 27.01% 24.71% 7.06% 7.01% 8.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.02% 22.05% 26.51% 18.68% 31.54% 28.65% 33.92% 71.03% -380.01% 10.93%
Return on Net Nonoperating Assets (RNNOA)
0.21% -4.74% -3.55% -1.46% -2.45% -2.50% -0.40% -0.14% -0.29% -0.54%
Return on Equity (ROE)
-0.90% 17.99% 22.72% 16.34% 28.16% 24.51% 24.32% 6.92% 6.72% 7.45%
Cash Return on Invested Capital (CROIC)
7.11% 22.58% 21.38% 16.84% 22.61% 15.38% 9.36% 1.69% -2.70% -2.88%
Operating Return on Assets (OROA)
3.60% 19.95% 24.75% 17.35% 29.08% 24.65% 26.13% 7.81% 9.78% 5.92%
Return on Assets (ROA)
-0.74% 13.71% 17.32% 11.82% 20.04% 16.69% 17.20% 4.50% 4.04% 4.89%
Return on Common Equity (ROCE)
-0.90% 17.99% 22.72% 16.34% 28.16% 24.51% 24.32% 6.92% 6.72% 7.45%
Return on Equity Simple (ROE_SIMPLE)
0.00% 18.39% 19.99% 20.40% 0.00% 14.49% 10.90% 5.43% 0.00% 0.23%
Net Operating Profit after Tax (NOPAT)
-0.15 2.88 3.80 2.46 4.01 3.49 3.21 0.89 0.86 1.06
NOPAT Margin
-0.31% 6.25% 7.73% 5.52% 9.52% 8.53% 8.18% 2.35% 2.40% 2.77%
Net Nonoperating Expense Percent (NNEP)
-0.10% 0.69% -0.24% -0.89% -0.93% -1.64% -9.20% -63.97% 387.03% -2.93%
Return On Investment Capital (ROIC_SIMPLE)
-0.20% - - - 6.34% - - - - -
Cost of Revenue to Revenue
74.65% 74.26% 72.99% 74.16% 71.99% 72.75% 71.25% 78.30% 77.90% 80.10%
SG&A Expenses to Revenue
23.54% 16.36% 15.77% 17.56% 14.03% 14.60% 16.26% 17.55% 16.25% 16.41%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.83% 16.66% 16.05% 17.86% 14.35% 14.93% 16.60% 17.91% 16.63% 16.76%
Earnings before Interest and Taxes (EBIT)
0.78 4.33 5.41 3.56 5.76 5.04 4.79 1.44 1.73 1.19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1.68 5.19 6.24 4.36 6.56 5.83 5.58 2.23 2.47 1.92
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
5.11 5.36 2.76 3.98 3.26 2.71 1.84 1.81 1.81 1.76
Price to Tangible Book Value (P/TBV)
6.82 7.19 3.78 5.61 4.71 4.07 2.88 2.97 3.03 2.84
Price to Revenue (P/Rev)
1.97 2.11 1.06 1.52 1.23 0.99 0.64 0.61 0.61 0.65
Price to Earnings (P/E)
40.71 29.15 13.82 19.52 17.33 18.70 16.89 33.39 93.07 770.80
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.46% 3.43% 7.24% 5.12% 5.77% 5.35% 5.92% 2.99% 1.07% 0.13%
Enterprise Value to Invested Capital (EV/IC)
6.36 7.12 3.25 4.51 3.73 2.95 1.86 1.80 1.77 1.79
Enterprise Value to Revenue (EV/Rev)
1.88 1.99 0.98 1.46 1.17 0.94 0.63 0.61 0.62 0.63
Enterprise Value to EBITDA (EV/EBITDA)
20.09 16.24 7.53 10.90 9.24 9.00 7.76 11.80 17.33 22.92
Enterprise Value to EBIT (EV/EBIT)
24.92 19.04 8.76 12.71 10.95 11.14 10.33 19.40 41.77 110.24
Enterprise Value to NOPAT (EV/NOPAT)
39.19 27.58 12.58 18.48 16.08 17.02 15.59 29.76 74.69 536.01
Enterprise Value to Operating Cash Flow (EV/OCF)
27.06 17.84 8.85 15.75 11.01 11.59 9.48 11.65 22.09 25.75
Enterprise Value to Free Cash Flow (EV/FCFF)
93.84 32.12 15.56 27.93 16.56 19.39 20.18 109.27 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.04 0.05 0.10 0.12 0.12 0.14 0.13
Long-Term Debt to Equity
0.00 0.00 0.00 0.02 0.02 0.08 0.09 0.10 0.11 0.11
Financial Leverage
-0.21 -0.22 -0.13 -0.08 -0.08 -0.09 -0.01 0.00 0.00 -0.05
Leverage Ratio
1.30 1.34 1.31 1.37 1.39 1.44 1.40 1.46 1.45 1.45
Compound Leverage Factor
1.30 1.34 1.30 1.35 1.38 1.41 1.36 1.35 1.37 1.35
Debt to Total Capital
0.00% 0.00% 0.00% 3.76% 4.33% 9.33% 10.33% 10.97% 12.03% 11.41%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 1.89% 1.98% 2.02% 2.15% 1.83% 2.31% 1.75%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 1.87% 2.35% 7.30% 8.18% 9.14% 9.72% 9.65%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 96.24% 95.67% 90.67% 89.68% 89.03% 87.97% 88.59%
Debt to EBITDA
0.00 0.00 0.00 0.11 0.14 0.36 0.49 0.79 1.28 1.73
Net Debt to EBITDA
0.00 0.00 0.00 -0.43 -0.52 -0.43 -0.12 0.11 0.41 -0.65
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.06 0.07 0.28 0.39 0.66 1.03 1.46
Debt to NOPAT
0.00 0.00 0.00 0.19 0.24 0.68 0.99 2.00 5.52 40.43
Net Debt to NOPAT
0.00 0.00 0.00 -0.72 -0.90 -0.81 -0.24 0.27 1.75 -15.11
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.09 0.13 0.53 0.78 1.67 4.46 34.21
Altman Z-Score
15.45 15.29 10.49 11.54 9.21 7.30 6.62 5.88 5.89 5.49
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.81 2.68 2.83 2.53 2.30 2.25 2.44 2.00 2.07 2.18
Quick Ratio
2.07 2.04 2.10 1.82 1.63 1.57 1.55 1.25 1.22 1.41
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-5.36 1.02 1.17 -1.99 3.67 2.45 1.83 -1.29 -1.63 -0.47
Operating Cash Flow to CapEx
-206.16% 488.27% 455.71% 62.62% 398.42% 578.63% 1,064.91% 171.79% 41.43% 463.63%
Free Cash Flow to Firm to Interest Expense
-1,786.34 255.69 24.85 -39.04 59.15 22.46 16.78 -12.41 -16.94 -6.06
Operating Cash Flow to Interest Expense
-859.67 1,862.75 139.23 30.31 77.37 61.37 22.28 29.11 3.63 54.13
Operating Cash Flow Less CapEx to Interest Expense
-1,276.67 1,481.25 108.68 -18.10 57.95 50.76 20.18 12.16 -5.13 42.45
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
2.17 2.12 2.25 2.18 2.13 2.00 2.14 2.05 2.02 1.90
Accounts Receivable Turnover
12.75 13.69 13.68 12.34 12.66 12.51 13.94 12.44 13.27 12.82
Inventory Turnover
15.55 15.03 14.24 13.90 12.56 12.46 12.82 12.92 12.81 13.34
Fixed Asset Turnover
7.53 7.49 7.53 7.14 7.33 7.13 7.15 6.93 6.90 6.60
Accounts Payable Turnover
13.57 13.21 17.28 12.63 13.11 12.66 18.69 12.98 15.73 13.17
Days Sales Outstanding (DSO)
28.62 26.67 26.68 29.59 28.82 29.18 26.18 29.34 27.52 28.48
Days Inventory Outstanding (DIO)
23.47 24.28 25.63 26.25 29.05 29.30 28.46 28.24 28.49 27.35
Days Payable Outstanding (DPO)
26.90 27.64 21.12 28.89 27.84 28.84 19.53 28.13 23.20 27.72
Cash Conversion Cycle (CCC)
25.20 23.31 31.19 26.95 30.03 29.64 35.11 29.46 32.80 28.12
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
55 51 53 54 50 49 51 50 50 48
Invested Capital Turnover
3.55 3.64 3.40 3.22 3.22 3.17 3.02 3.00 2.93 2.89
Increase / (Decrease) in Invested Capital
5.21 1.86 2.63 4.46 0.34 1.04 1.38 2.18 2.49 1.52
Enterprise Value (EV)
351 363 173 243 187 145 95 89 88 86
Market Capitalization
367 383 188 253 197 152 96 88 86 89
Book Value per Share
$4.85 $4.84 $4.62 $4.32 $4.11 $3.82 $3.56 $3.33 $3.07 $3.26
Tangible Book Value per Share
$3.63 $3.61 $3.38 $3.07 $2.85 $2.54 $2.27 $2.03 $1.83 $2.01
Total Capital
72 72 68 66 63 62 58 55 54 57
Total Debt
0.00 0.00 0.00 2.49 2.73 5.76 6.01 6.01 6.50 6.50
Total Long-Term Debt
0.00 0.00 0.00 1.24 1.48 4.51 4.76 5.01 5.25 5.50
Net Debt
-17 -21 -15 -9.54 -10 -6.87 -1.44 0.80 2.06 -2.43
Capital Expenditures (CapEx)
1.25 1.53 1.44 2.47 1.20 1.16 0.23 1.76 0.84 0.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)
11 7.50 11 12 9.63 9.14 11 9.56 11 9.22
Debt-free Net Working Capital (DFNWC)
28 28 25 24 23 22 19 15 15 18
Net Working Capital (NWC)
28 28 25 23 22 21 18 14 14 17
Net Nonoperating Expense (NNE)
0.01 -0.09 0.02 0.04 0.04 0.08 0.05 0.06 0.14 0.07
Net Nonoperating Obligations (NNO)
-17 -21 -15 -9.54 -10 -6.87 -1.44 0.80 2.06 -2.43
Total Depreciation and Amortization (D&A)
0.90 0.86 0.84 0.80 0.80 0.79 0.79 0.78 0.73 0.73
Debt-free, Cash-free Net Working Capital to Revenue
6.09% 4.12% 6.10% 7.15% 6.02% 5.94% 7.49% 6.57% 7.59% 6.75%
Debt-free Net Working Capital to Revenue
15.04% 15.42% 14.38% 14.36% 14.26% 14.15% 12.42% 10.16% 10.73% 13.28%
Net Working Capital to Revenue
15.04% 15.42% 14.38% 13.61% 13.48% 13.34% 11.60% 9.47% 9.84% 12.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.02) $0.20 $0.26 $0.17 $0.26 $0.23 $0.22 $0.06 $0.05 $0.06
Adjusted Weighted Average Basic Shares Outstanding
14.77M 14.80M 14.73M 14.69M 14.67M 14.68M 14.65M 14.65M 15.40M 15.49M
Adjusted Diluted Earnings per Share
$0.00 $0.19 $0.25 $0.16 $0.25 $0.23 $0.21 $0.06 $0.05 $0.06
Adjusted Weighted Average Diluted Shares Outstanding
15.13M 15.27M 15.20M 15.22M 15.10M 15.10M 15.08M 15.03M 15.72M 15.85M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.20M 14.82M 14.79M 14.71M 14.69M 14.69M 14.67M 14.66M 14.64M 15.50M
Normalized Net Operating Profit after Tax (NOPAT)
0.50 2.88 3.80 2.46 4.01 3.49 3.21 0.89 1.37 1.06
Normalized NOPAT Margin
1.06% 6.25% 7.73% 5.52% 9.52% 8.53% 8.18% 2.35% 3.83% 2.77%
Pre Tax Income Margin
1.65% 9.39% 10.90% 7.86% 13.53% 12.05% 11.94% 3.53% 4.56% 2.92%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
259.67 1,082.50 115.02 69.78 92.89 46.22 43.98 13.87 18.03 15.45
NOPAT to Interest Expense
-49.00 720.44 80.89 48.33 64.65 32.00 29.45 8.57 8.95 13.71
EBIT Less CapEx to Interest Expense
-157.33 701.00 84.47 21.37 73.47 35.61 41.89 -3.08 9.28 3.78
NOPAT Less CapEx to Interest Expense
-466.00 338.94 50.34 -0.08 45.23 21.40 27.36 -8.37 0.20 2.03
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 432.58% 0.00%

Frequently Asked Questions About Lifeway Foods' Financials

When does Lifeway Foods's fiscal year end?

According to the most recent income statement we have on file, Lifeway Foods' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Lifeway Foods' net income changed over the last 2 years?

Lifeway Foods' net income appears to be on an upward trend, with a most recent value of $9.03 million in 2024, rising from $924 thousand in 2022. The previous period was $11.37 million in 2023. View Lifeway Foods' forecast to see where analysts expect Lifeway Foods to go next.

What is Lifeway Foods's operating income?
Lifeway Foods's total operating income in 2024 was $13.85 million, based on the following breakdown:
  • Total Gross Profit: $48.57 million
  • Total Operating Expenses: $34.72 million
How has Lifeway Foods revenue changed over the last 2 years?

Over the last 2 years, Lifeway Foods' total revenue changed from $141.57 million in 2022 to $186.82 million in 2024, a change of 32.0%.

How much debt does Lifeway Foods have?

Lifeway Foods' total liabilities were at $18.64 million at the end of 2024, a 12.2% decrease from 2023, and a 13.0% decrease since 2022.

How much cash does Lifeway Foods have?

In the past 2 years, Lifeway Foods' cash and equivalents has ranged from $4.44 million in 2022 to $16.73 million in 2024, and is currently $16.73 million as of their latest financial filing in 2024.

How has Lifeway Foods' book value per share changed over the last 2 years?

Over the last 2 years, Lifeway Foods' book value per share changed from 3.07 in 2022 to 4.85 in 2024, a change of 58.1%.



This page (NASDAQ:LWAY) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners